TXMD - TherapeuticsMD, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue16,099.4616,777.71319,356.4520,142.898
Cost of Revenue2,737.6522,636.9434,185.7084,506.673
Gross Profit13,361.80814,140.7715,170.74215,636.225
Operating Expenses
Research Development27,299.13833,852.99353,943.47772,042.774
Selling General and Administrative115,988.95457,703.3751,348.41428,721.236
Non Recurring----
Others----
Total Operating Expenses146,319.6394,406.423109,610.05105,333.083
Operating Income or Loss-130,220.17-77,628.71-90,253.6-85,190.185
Income from Continuing Operations
Total Other Income/Expenses Net-2,396.99703.33378.141113.161
Earnings Before Interest and Taxes-130,220.17-77,628.71-90,253.6-85,190.185
Interest Expense-4,677.834-4,677.834-4,677.834-4,677.834
Income Before Tax-132,617.16-76,925.38-89,875.459-85,077.024
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-132,617.16-76,925.38-89,875.459-85,077.024
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-132,617.16-76,925.38-89,875.459-85,077.024
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-132,617.16-76,925.38-89,875.459-85,077.024